Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Haemonetics (HAE), is a global provider of hematology and blood management products and solutions. The company delivered...
— Jack McPherson and Dave Adams
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Haemonetics Corporation
Haemonetics Corporation ($HAE), constituting 2.7% of the fund, develops and distributes specialized hematology technologies, blood management products, and plasma collection solutions. The manager is...
Haemonetics ($HAE) provides automated plasma collection systems, blood processing hardware, and specialized surgical interventional technologies. The manager's bullish...
Haemonetics Corporation ($HAE), which represents 3.1% of the portfolio, designs and commercializes hematology devices, blood separation equipment, and specialized vascular closure solutions. Ariel is constructive...
More institutional theses from Aristotle Small/Mid Cap Equity
Huron Consulting Group provides specialized technology implementation, data analytics, and advisory services primarily to clients in healthcare, higher education, and commercial enterprises. The manager maintains...
MACOM Technology Solutions manufactures high-performance analog, radio frequency, and optical semiconductor components. The manager remains...
Bentley Systems provides mission-critical engineering software and digital twin technology utilized by civil engineers and infrastructure owners worldwide to design, construct, and maintain large-scale physical assets. The fund initiated...